FluoroPharma Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
FPMI
- Investments
-
2
FluoroPharma General Information
Description
FluoroPharma Medical Inc is a USA-based biopharmaceutical company. It specializes in developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The company focuses on the development of novel cardiovascular imaging agents which detect and assess acute and chronic forms of coronary artery disease (CAD). The company's clinical-stage molecular imaging pharmaceutical product candidates are 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). The company operates in a single segment being Biopharmaceutical research and development.
Contact Information
Website
www.fluoropharma.comCorporate Office
- 8 Hillside Avenue
- Suite 108
- Montclair, NJ 07042
- United States
Corporate Office
- 8 Hillside Avenue
- Suite 108
- Montclair, NJ 07042
- United States
FluoroPharma Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 7.92K |
FluoroPharma Financials Summary
As of 31-Dec-2016, FluoroPharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2016 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 | FY 2014 31-Dec-2014 |
|---|---|---|---|---|
| EV | 9,412 | 9,412 | 12,648 | 12,998 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (744) | (744) | (2,244) | (3,984) |
| Net Income | (2,050) | (2,050) | (3,164) | (4,131) |
| Total Assets | 335 | 335 | 839 | 820 |
| Total Debt | 5,825 | 5,825 | 4,349 | 2,123 |
FluoroPharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
FluoroPharma Comparisons
Industry
Financing
Details
FluoroPharma Competitors (2)
One of FluoroPharma’s 2 competitors is Bracco Group, a Private Debt Financed company based in Milan, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bracco Group | Private Debt Financed | Milan, Italy | ||||
| Life Molecular Imaging | Corporate Backed or Acquired | Berlin, Germany |
FluoroPharma Signals
FluoroPharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
FluoroPharma Acquisitions (2)
FluoroPharma’s most recent deal was a Merger/Acquisition with Ground Fluor Pharmaceuticals. The deal was made on 09-Jun-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ground Fluor Pharmaceuticals | 09-Jun-2016 | Merger/Acquisition | Drug Discovery | ||
| Commercial E Waste Management | 04-Jun-2011 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
FluoroPharma FAQs
-
When was FluoroPharma founded?
FluoroPharma was founded in 2003.
-
Where is FluoroPharma headquartered?
FluoroPharma is headquartered in Montclair, NJ.
-
What is the size of FluoroPharma?
FluoroPharma has 4 total employees.
-
What industry is FluoroPharma in?
FluoroPharma’s primary industry is Biotechnology.
-
Is FluoroPharma a private or public company?
FluoroPharma is a Public company.
-
What is FluoroPharma’s stock symbol?
The ticker symbol for FluoroPharma is FPMI.
-
Who are FluoroPharma’s competitors?
Bracco Group and Life Molecular Imaging are competitors of FluoroPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process